End to End Pharmacology Solutions
Bridging the Gap Between Research and Clinic

Leverage a range of research and development solutions to improve the productivity of oncology drug development

Learn more >
Champions NSCLC Indication Screen

Clinically Relevant Lung Cancer PDX Cohort Screening Opportunity Enrollment Ends Nov 30th

Learn More >
Champions SynScreen

Large scale syngeneic screening opportunity across 6 lines Enrollment ends Oct 31

Learn More >
Champions Oncology AML VitroScreen

Large-Scale in vitro screening opportunity of primary AML models with reduced cost

Learn More >
On-Demand Webinar Series

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Watch it Now >
Access the Champions TumorGraft Database

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Request Access >
Read Our Latest Newsletter
Learn More >
Hematology<br>Oncology Models

Hematology
Oncology Models

Learn more >
Champions <br>TumorGraft Database

Champions
TumorGraft Database

Learn more >
Co-Clinical Trials

Co-Clinical Trials

Learn more >
Oncology

Latest News

Champions Oncology Reports Record Quarterly Revenue of $6.2 Million

Learn more >

Champions Oncology Granted Full Accreditation by the AAALAC

Learn more >